Related Experiment Videos
[Experimental studies with timolol: a new ocular hypotensive agent (author's transl)]
Journal Francais D'Ophtalmologie
|December 1, 1978
Summary
Timolol maleate ophthalmic solution effectively lowers intraocular pressure (IOP) in glaucoma models. Animal studies confirm its efficacy and safety for treating elevated IOP.
Area of Science:
- Ophthalmology
- Pharmacology
- Veterinary Medicine
Context:
- Glaucoma and elevated intraocular pressure (IOP) are significant ophthalmic conditions.
- Animal models are crucial for preclinical evaluation of glaucoma therapies.
- Timolol maleate is a widely used ophthalmic solution for IOP management.
Purpose:
- To review animal pharmacology data supporting timolol maleate ophthalmic solution's clinical use.
- To evaluate timolol's effect on normal and experimentally elevated IOP in rabbits.
- To compare timolol's efficacy against epinephrine and assess its beta-adrenergic blocking activity.
Summary:
- Timolol maleate demonstrated efficacy in reducing IOP in normal and hypertensive rabbit eyes.
- The drug's ability to block beta-adrenergic receptors was confirmed.
- Pharmacokinetic studies detailed timolol's distribution within ocular tissues, alongside toxicological assessments.
Impact:
- Provides a comprehensive review of preclinical data for timolol maleate in glaucoma therapy.
- Supports the established clinical use of timolol maleate for managing elevated IOP.
- Contributes to understanding the pharmacological profile and safety of timolol maleate.